Plasma Insulin/Erythrocytic Aldose Reductase Ratio as a Predictor for Hepatocellular Carcinoma among Type II Diabetics and Hepatitis C Virus-infected Patients

BACKGROUND: Hepatocellular carcinoma (HCC) is a possible oncogenic progression during persistent hepatitis C-infection +/- type II diabetes mellitus (DM). We aim to investigate the plasma insulin, erythrocytic aldose reductase (AR) and sorbitol dehydrogenase (SDH) as possible predictive tools for HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Hamid, Nabil Mohie, Sherif, Mohamad H, Al Samahy, Asmaa E, Abdelhamid, Moustafa Salaheldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930971/
https://www.ncbi.nlm.nih.gov/pubmed/36444594
http://dx.doi.org/10.31557/APJCP.2022.23.11.3815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930971/
https://www.ncbi.nlm.nih.gov/pubmed/36444594
http://dx.doi.org/10.31557/APJCP.2022.23.11.3815

Ejemplares similares